O-003

Oxymorphon-D₃ -Lösung

100 μg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant^®

• Empirische Formel (Hill-System): C₁₇H₁₆NO₄D₃
• CAS-Nummer: 145225-03-2
• Molekulargewicht: 304.36
• EG-Nummer: 200-659-6
• MDL-Nummer: MFCD00673302
• UNSPSC-Code: 41116107
• PubChem Substanz-ID: 329818812
• NACRES: NA.24

Eigenschaften

• Qualität: certified reference material
• Qualitätsniveau: 300
• Form: liquid
• Leistungsmerkmale: Snap-N-Spike^®/Snap-N-Shoot^®
• Verpackung: ampule of 1 mL
• Hersteller/Markenname: Cerilliant^®
• drug control: Narcotic Licence Schedule A (Switzerland); estupefaciente (Spain); Decreto Lei 15/93: Tabela IA (Portugal)
• Konzentration: 100 μg/mL in methanol
• Methode(n): gas chromatography (GC): suitable; liquid chromatography (LC): suitable
• Anwendung(en): forensics and toxicology
• Format: single component solution
• Lagertemp.: −20°C
• SMILES String: [2H]C([2H])([2H])N1CC[C@]23[C@H]4Oc5c(O)ccc(C[C@@H]1[C@]2(O)CCC4=O)c35
• InChI: 1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1/i1D3
• InChIKey: UQCNKQCJZOAFTQ-ZXTOONLTSA-N

Beschreibung

Allgemeine Beschreibung

A stable-labeled internal standard suitable for quantitation of oxymorphone levels in urine, serum, or plasma by LC/MS or GC/MS for urine drug testing, pain prescription monitoring, clinical toxicology, forensic analysis or pharmaceutical research. Oxymorphone, sold under trade names such as Opana^®, Numorphan^®, and Numorphone, is an opiate analgesic indicated for the relief of moderate to severe pain.

Anwendung

• Photoluminescence sensor development: Oxymorphone-D3 solution was utilized in the creation of a photoluminescence sensor for metal detection, incorporating symmetrical ligands on a porous silicon surface, demonstrating its application in analytical methodologies for environmental monitoring and material analysis (Saleem et al., 2024).
• Healthcare budget impact analysis: In a study examining the economic implications of healthcare treatments, Oxymorphone-D3 solution was mentioned as part of a broader analysis on budget impacts, showcasing its relevance in pharmaceutical economics and decision-making processes within healthcare management (Wilson et al., 2024).
• Co-solvency and drug solubilization research: Research on drug solubilization techniques referred to the use of Oxymorphone-D3 solution to study the combined effects of co-solvency and inclusion complex formation, providing insights into formulation science and bioavailability enhancement in pharmaceutical development (Dehghan et al., 2024).

Rechtliche Hinweise

CERILLIANT is a registered trademark of Merck KGaA, Darmstadt, Germany

Numorphan is a registered trademark of Endo Pharmaceuticals Inc.

Opana is a registered trademark of Endo Pharmaceuticals Inc.

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Merck KGaA, Darmstadt, Germany

Sicherheitshinweise

• Piktogramme: GHS02,GHS06,GHS08
• Signalwort: Danger
• H-Sätze: H225,H301 + H311 + H331,H370
• P-Sätze: P210 - P280 - P301 + P310 + P330 - P302 + P352 + P312 - P304 + P340 + P311
• Gefahreneinstufungen: Acute Tox. 3 Dermal - Acute Tox. 3 Inhalation - Acute Tox. 3 Oral - Flam. Liq. 2 - STOT SE 1
• Zielorgane: Eyes
• Lagerklassenschlüssel: 3 - Flammable liquids
• WGK: WGK 1
• Flammpunkt (°F): 49.5 °F - closed cup
• Flammpunkt (°C): 9.7 °C - closed cup